www.pharmavoice.com

SPECIAL ISSUE

���

� � �� �� � �� �

� � �� �� � �� �

SILAICEPS

EUSS

NOITACILBUP

Their Word...

PUBLISHER Lisa BanketEDITOR Taren Grom

CREATIVE DIRECTOR Marah Walsh

MANAGING EDITORDenise MyshkoSENIOR EDITORRobin Robinson

FEATURES EDITORKim Ribbink

CONTRIBUTING EDITOR Carolyn Gretton

DESIGN ASSOCIATEAriel Medel

NATIONAL ACCOUNT MANAGERSTrish KaneCathy Tracy

WEBCAST NETWORK PRODUCERDaniel Limbach

CIRCULATION ASSISTANTKathy Deiuliis

Copyright 2012by PharmaLinx LLC, Titusville, NJ

Printed in the U.S.A.Volume Twelve, Number Seven

PharmaVOICE (ISSN: 1932961X) is published monthly ex-cept joint issues in July/Aug. and Nov./Dec., by Pharma LinxLLC, P.O. Box 327, Titusville, NJ 08560. Periodicals postagepaid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVOICE,P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVOICE Coverage and Distribution:Domestic subscriptions are available at $190 for oneyear (10 issues). Foreign subscriptions: 10 issuesUS$360. Contact PharmaVOICE at P.O. Box 327, Ti-tusville, NJ 08560. Call us at 609.730.0196 or FAX yourorder to 609.730.0197.

Contributions: PharmaVOICE is not responsible for un-solicited contributions of any type. Unless otherwiseagreed in writing, PharmaVOICE retains all rights on ma-terial published in PharmaVOICE for a period of sixmonths after publication and reprint rights after that pe-riod expires. E-mail: tgrom@pharmavoice.com.

Change of address: Please allow six weeks for a changeof address. Send your new address along with your sub-scription label to PharmaVOICE, P.O. Box 292345, Kettering,OH 45429-0345. Call us at 800.607.4410 or FAX your changeto 937.890.0221. E-mail: mwalsh@pharmavoice.com.

IMPORTANT NOTICE: The post office will not forwardcopies of this magazine. PharmaVOICE is not respon-sible for replacing undelivered copies due to lack of orlate notification of address change.

Advertising in PharmaVOICE: To advertise in Pharma - VOICE please contact our Advertising Department atP.O. Box 327, Titusville, NJ 08560, or telephone us at609.730.0196. E-mail: lbanket@pharmavoice.com.

Send your letters to feedback@pharma voice.com.Please include your name, title, company, and busi-ness phone number. Letters chosen for publicationmay be edited for length and clarity. All submissionsbecome the property of PharmaLinx LLEU.

Letters...

Printed on recycled paper

tgrom@pharmavoice.com

Taren GromEditor

THE FORUM FOR THE INDUSTRY EXECUTIVE

Regards,

Letter from the Editor

DENISE MYSHKO

Managing Editor

This year’s PV 100

honorees are true

leaders in the industry;

they are admired by

their peers as they work tirelessly

to address the challenges facing

the industry.

ROBIN ROBINSON

Senior Editor

From the scientists to

the marketers, from the

entrepreneurs to the

mentors, and all of the

other fascinating leaders

represented in our PV 100 issue,

the one common denominator is

their singular dedication to

improving the world around

them.

KIM RIBBINK

Features Editor

The impact greatl eaders and mentorshave on those they interact with stands outin this year’s

PharmaVOICE 100; it’s apparentthat what they give back is farmore important than their individual achievements.

Volume 12 • Number 7

COMINGin September> Behavioral Marketing> E-Patients

>Diagnostics

> Sunshine Act

>Global Product Registration> Emerging Market — India>C-Suite — Pharmaceutical

Companies

> Showcase Features — Data ManagementMarketing

Inspiration...TRY NOT TO BECOME A MAN OF SUCCESS BUT A MAN OF VALUE. — ALBERT EINSTEIN. Einstein might have been describing this year’s Pharma VOICE 100

honorees. This distinguished group of individuals — men and women— are committed to achieving results that lead to the greater good fortheir colleagues, their companies, the patients they serve, and their fel-low (wo)man.Every year, we have the distinct honor of showcasing 100 extraordi-

nary leaders, many of them unsung heroes who sit outside the C-suite, al-though we have plenty of these too. And it is only because of you, ourreaders, that we have the opportunity to share them with you. This special publication, now in its eighth year, is truly the feel-good

issue of the year and one of the most anticipated. Each year the list ofhonorees is more diverse and eclectic, which is a reflection of the chang-ing life-sciences landscape and the scope of our readership and reach. (Weeven received a nomination from a Hollywood A-lister.) Over the past several months, we have had the privilege to get to know

this year’s PharmaVOICE 100. And I want to thank each of them for tak-ing the time to share their very personal stories with us, which we can nowshare with you. They certainly demonstrate how passion, integrity, and in-novative thinking can move the needle to positively impact health andwellness for millions. To make the issue easy to navigate, we have divided the honorees into

categories that we believe best capture their expertise, which is no easytask as each could easily fit into several of the following sections: com-manders and chiefs, entrepreneurs, change agents, clinical specialists, re-searchers and scientists, marketers, creatives, patient advocates, technol-ogists, and mentors.Please join us in extending warm congratulations to this year’s

PharmaVOICE 100. Don’t forget to check out the exclusive bonuscontent found only in our digital edition, which can be accessed viathe QR code at the end of each profile, or via our website at pharma -voice.com, just click on the PharmaVOICE 100 cover image. Wecan’t wait to see who makes next year’s list. Submit your nominationsfor 2013 now.

2 July/August 2012 � PharmaVOICE

Andrew Stanger played

trombone in a marching

band.

Did You Know? ?

Andrew STANGERDigitizing Education

ndrew Stanger’s approach to creating en-gaging and effective digital programsfor the pharma industry is to use newtechnologies and leverage existing

ones in the most cost-effective ways forclients. The goal is to deliver educational andentertaining programs to medical profession-als and consumers.As president of GenR Media, a digital

media company that works exclusively withinthe pharmaceutical and healthcare field, Mr.Stanger’s greatest strength is that he doesn’tsee questions or problems, he sees answers andsolutions. With more than 13 years experience in

digital marketing, he brings energy and vital-ity to discussions about healthcare. Mr.Stanger’s inspiring appetite for all things dig-ital and healthcare related makes for an im-pressive display of passionate exposition whencreating campaigns. In 2009, he helped found GenR Media

during the worst recession in a generation.Attesting to his business prowess, the com-pany was profitable that year, and in each sub-sequent year since its inception. Mr. Stanger measures his own success

by the success of his clients. All GenRprograms are designed to create the max-imum return for clients, and this of coursecreates a relationship of mutual benefit.This symbiotic relationship means totalinvestment for Mr. Stanger’s teams and afull stake in the lifetime of all projects. Mr. Stanger inspires all of those around

him through his market insights, leader-ship, support, and most notably, his gen-erosity. He allocates 5% of GenR Mediaprofits as charitable donations each quar-ter. This philanthropy is not limited to just

himself, as he requests suggestions fromhis colleagues and clients for organizationsto donate to each quarter. Organizations he has donated to include

the Yankees Foundation, the AmericanHeart Association, Susan G. Komen ForThe Cure, Animal Haven, AIDS WalkNew York, and the Deborah HospitalFoundation to name just a few. PV

PASSIONATE. ENTERTAINING.NAME: Andrew Stanger

CURRENT POSITION: President, GenR Media

DATE AND PLACE OF BIRTH: August 1977; New Jersey

EDUCATION: B.S., marketing/B.A., psychology, RutgersUniversity; MBA, marketing, Zicklin School of Business, Baruch College, CUNY

FIRST JOB: Marvel Entertainment

PROFESSIONAL MENTORS: Marty Cearnal; FlorenceMichelet; Howard Kroplick; James Bargon; SusanBerkley; Stephen Glicker

AWARDS AND HONORS: Omni Intermedia, Telly,eHealthcare Leadership

GIVING BACK: Yankees Foundation; Damon RunyonCancer Research; Susan G. Komen Deborah Hospital

WORDS TO LIVE BY: Never follow in another man’sfootsteps; you never know what he might havestepped in

TWITTER ADDRESS: @astanger; @genrmedia

CONNECTED VIA: LinkedIn; Facebook; Twitter;Google+; YouTube

Andrew Stanger’s inspiringappetite for all things digitaland healthcare related makesfor an impressive leader.

A

3PharmaVOICE � July/August 2012

The Entrepreneurs

Andrew STANGER

Andrew Stanger measureshis own success by thesuccess of his clients.

Digital For All

ndrew Stanger, an innovator in digitalmedia and marketing, co-foundedGenR Media in 2009. Under Mr.

Stanger’s guidance, the company offers a suiteof programs designed to educate, captivate,and stimulate audiences in the healthcare com-munity, including pharmaceutical companies,medical education agencies, and associations/institutions. Having cofounded the company during a

significant economic downturn, Mr. Stangersays one of his biggest career highlights oc-

curred when GenR received its first large ac-count five months later.Mr. Stanger has worked in medical educa-

tion since 1999, specializing in content deliv-ery through digital media to increase reach andimprove healthcare outcomes. Mr. Stanger has developed successful pro-

grams in various therapeutic areas includingdry eye, glaucoma, fungal disease, cardiovascu-lar, respiratory, rheumatoid arthritis, oncology,women’s health and hepatitis. Mr. Stanger’s experience includes the man-

agement and implementation of programs inboth the Continuing Medical Education andPromotional arenas including satellite sym-posia, consultant meetings, advisory boards,investigator meetings, CD-ROMs/DVDs,iPad apps, supplements, slide kits, and Web-based programs. Mr. Stanger is very active in online com-

munities and discussions regarding technol-ogy and healthcare, from participating inLinkedIn groups to being followed on Twit-ter.He maintains an active and diverse profile

in the field. His regular GenR Twitter feed onindustry-related news has many followers that

count on him to provide the most current andinteresting stories in the pharma industrytoday. Mr. Stanger has received awards for his

work in pharma, including the Telly Awards,Omni Awards, and eHealthcare Leadershipawards.Mr. Stanger graduated Rutgers University

with a BS in marketing and a BA in psychol-ogy and received his MBA in marketing fromZicklin School of Business, CUNY. PV

FAMILY: Parents, Marvin and Ethel Stanger; twobrothers, Steve and Larry

HOBBIES: Watching the Yankees; running; museums; going to shows in New York; movies;concerts

FAVORITE BOOK: The World According to Garp byJohn Irving

FAVORITE MOVIE: Batman (1989)

MOST UNUSUAL PLACE VISITED: Chapel of Bones inEvora, Portugal

Getting Personal withANDREW STANGER !

A

The Entrepreneurs

4 July/August 2012 � PharmaVOICE

J. Martin CarrollBoehringer Ingelheim

Peter KirkWorldOne

Dr. Patrice MatchabaNovartis Pharmaceuticals

Dr. Marie FoeghAgile Therapeutics

Dr. Sreedhar TirunagariMakroCare ClinicalResearch

Scott RichardsonPfizer

Todd LaRochePalio

Cindy ParrottCommunity Health

Systems

Kim BoerickeQuintiles

Dr. Leo FrancisPublicis Healthcare

Communications Group

THE COMMANDERS & CHIEFS............................Adrian Adams ............................Auxilium PharmaceuticalsRich Altus................................................................PDR NetworkMatt Baker ..............................................................Compass IRB J. Martin Carroll ..................................Boehringer IngelheimLeo Francis, Ph.D. ....................................Publicis Healthcare

Communications GroupLisa Costantino ......................................................EMD SeronoDavid de Graaf, Ph.D. ..................................................SelventaAsaf Evenhaim ..............................................Crossix SolutionsKaren Ferrante, M.D...............................................Millennium:

The Takeda Oncology CompanyKelly Gratz ..........................inVentiv Commercial SolutionsMark Hanley ..........................Clinical Research AdvantageRick Keefer............................Publicis Touchpoint SolutionsIan Kelly ....................................................................Red NucleusRoger Korman, Ph.D...........................................DMD/AptilonLaurent Labrune..Cegedim Relationship ManagementSanjit Singh Lamba......................Eisai Pharmatechnology Jeffrey Litwin, M.D. ..........................eResearch TechnologyTina Nova, Ph.D. ................Genoptix, a Novartis companyJim Ogle ..................................................................INC Research Michael Parisi ............Ogilvy CommonHealth WorldwideAdelene Perkins ............................Infinity PharmaceuticalsJack Phillips ................................................Roche DiagnosticsRobert Previdi ......................................................................PSKWMichael Rutstein ..................Strikeforce CommunicationsEd Seguine ..................................................................Clinical InkTodd Sherer, Ph.D. ....................................The Michael J. Fox

Foundation for Parkinson’s ResearchDonato Tramuto ............Physicians Interactive HoldingsSteve Viviano ................................................................ICC LoweAnna Walz ....................Medisys Health Communications Stephen Wray ....................................................Cadient Group

THE ENTREPRENEURS ........................................Alexis Borisy ......................................................Warp Drive BioBetsy Brown ....................................Trio Clinical Resourcing,

an Aptiv Solutions companyFaruk Capan..................................................Intouch SolutionsMarco Chacón, Ph.D.............................Paragon BioservicesTerri Clevenger ....Continuum Health CommunicationsBrad Doerschuk ................................PharmaMed ResearchMichael Fergusson............................................Ayogo GamesPatricia Furlong ......Parent Project Muscular DystrophyYuichi Iwaki, M.D., Ph.D. ......................................MediciNovaAllison Kalloo..........................................Clinical AmbassadorPeter Kirk ......................................................................WorldOneIlyssa Levins ....Center for Communication ComplianceKevin Lustig, Ph.D.........................................The Assay DepotMario Martinez II ..................................................360 VantageRick Morrison......................................Comprehend SystemsDarlene Panzitta ................................DSP Clinical ResearchTobias Ritter, Ph.D. ..............................SciFluor Life SciencesLeerom Segal ..........................................................Klick HealthKabir Shahani................................................................AppatureLaura Shawver, Ph.D. ..............................Cleave BiosciencesAndrew Stanger ....................................................GenR MediaKenneth Tomaszewski, Ph.D. ................................KJT GroupWendy White ..................................................Siren Interactive

THE CHANGE AGENTS ........................................Lee Babiss, Ph.D.......................................................................PPDJeff Berkowitz ..............................................................Walgreen

THE CHANGE AGENTS (continued)Kathleen Castore ........................................................Sanofi USCathryn Clary, M.D. ..................Ipsen BiopharmaceuticalsMarianne Eisenmann ........Chandler Chicco CompaniesLeigh Householder ......................................GSW WorldwideAmir Kalali, M.D. ............................................................Quintiles Dale Kummerle, Pharm.D. ..............Bristol-Myers SquibbBetsy Lahue ......................................................................Becton,

Dickinson and CompanyPatrice Matchaba, M.D. ............Novartis PharmaceuticalsDiego Miralles, M.D.........Janssen Healthcare InnovationRobert Peters ........................MicroMass CommunicationsPaul Shawah ......................................................Veeva SystemsAdam Sherlock ........................................................................CSCJay Philip Siegel, M.D.....................................................Janssen

Research & DevelopmentMartin VanTrieste, R.Ph. ................................................AmgenTimothy Wright, M.D...................................Novartis Pharma

THE RESEARCHERS & SCIENTISTS ....................Jerome Boscia, M.D. ......................................................Janssen

Research & Development Elliot Ehrich, M.D. ........................................................AlkermesMarie Foegh, M.D. ....................................Agile Therapeutics

THE CLINICAL SPECIALISTS................................Gaynor Anders......................................................................MMGOlivia Montaño-Tritz ..................................................SynteractGraham Nicholls....................Almac Clinical TechnologiesSheila Rocchio..........................................................................PHTSreedhar Tirunagari, M.D. ....................................MakroCare

Clinical Research

THE MARKETERS..................................................Nancy Beesley ..........................................................HCB HealthTimmy Garde ........................Star Group CommunicationsShannon Hartley..............................................................RosettaMike Innaurato ................................................Purdue PharmaScott Richardson..................................................................PfizerJeff Spanbauer ................Healthcare Regional Marketing Christopher Tobias, Ph.D. ............................................DudnykSaru Wade ........................................Vertex PharmaceuticalsSteven Walker........................................................MedImmune

THE CREATIVES ....................................................Todd LaRoche ........................................................................PalioAbby Mansfield ........................................Topin & AssociatesJosh Prince ......................................................The CDM Group

THE TECHNOLOGISTS..........................................Robert Holmes, Ph.D. ....................................................QformaMarco van Doeveren ....Medidata Solutions Worldwide

THE PATIENT ADVOCATES ..................................Dyan Bryson................................Inspired Health StrategiesCheryl Dewey ................Blue Chip Healthcare Marketing Cindy Parrott ..........................Community Health Systems

THE MENTORS......................................................Kim Boericke ..................................................................Quintiles Tami Klerr-Naivar ....................................................................PRAJoe Martinez ................................Optimer PharmaceuticalsChuck McLeester ..............Roska Healthcare AdvertisingLinda Rosenes ......................................................................Pfizer

Who’s on the List — 2012 Indexed by Section

Index by Section

5PharmaVOICE � July/August 2012